Back to Search
Start Over
Cardiovascular Effects of 3 Months of Treatment with GLP-1 Receptor Agonist Exenatide and DPP-4 Inhibitor Linagliptin: The SAFE-GUARD Trial
- Authors :
- Mraz, Milos
Chytilova, Eva
Klouckova, Jana
Trachta, Pavel
Skrha, Jan
Krizova, Jarmila
Petrak, Ondrej
Krupicka, Jan
Tuka, Vladimir
Jaroslav Kudlicka
Kratka, Zuzana
Dostalova, Gabriela
Malik, Jan
Haluzik, Martin
- Source :
- ResearcherID
Details
- Database :
- OpenAIRE
- Journal :
- ResearcherID
- Accession number :
- edsair.dedup.wf.001..4e957dacd3673497ca844ac75e055cdb